In Vitro and In Vivo Animal Models in Priapism Research

Journal of Sexual Medicine

Volumn 8, Issue 2, 2011, Pages 347-359

  Dong, Qiang ^a   Deng, Shi ^a   Wang, Run ^b   Yuan, Jiuhong ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

In Vitro Animal Models; In Vivo Animal Models; Ischemic Priapism

Indexed keywords

OXYGEN;

ARTIFICIAL VENTILATION; CELL CULTURE; CELL HYPOXIA; CORPORA CAVERNOSA SMOOTH MUSCLE; GENE INACTIVATION; GENE TRANSFER; GENETIC ENGINEERING; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SICKLE CELL; SMOOTH MUSCLE; TRANSGENIC MOUSE; UTERUS;

EID: 79551484587     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.02052.x     Document Type: Review

References (59)

1. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID, Members of the Erectile Dysfunction Guideline Update Panel, Americal Urological Association. American urological association guideline on the management of priapism. J Urol 2003;170:1318-24.
2. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: Pathogenesis, epidemiology, and management. J Sex Med 2010;7:476-500.
3. Hakim LS, Kulaksizoglu H, Mulligan R, Greenfield A, Goldstein I. Evolving concepts in the diagnosis and treatment of arterial high flow priapism. J Urol 1996;155:541-8.
4. Yuan JH, DeSouza R, Westney OL, Wang R. Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian J Andro 2008;10:88-101.
5. Pautler SE, Brock GB. Priapism. Urol Clin North Am 2001;28:391-403.
6. Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction and priapism. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ, Kavoussi AR, Novick AC, Partin AW, Peters CA, eds. Campbell's urology. Philadelphia: WB Saunders; 2002:1610-96.
7. Burnett AL. Pathophysiology of priapism: Dysregulatory erection physiology thesis. J Urol 2003;170:26-34.
8. Lue TF. Erectile dysfunction. N Engl J Med 2000;42:1802-13.
9. Juenemann KP, Lue TF, Abozeid M, Hellstrom WJ, Tanagho EA. Blood gas analysis in drug-induced penile erection. Urol Int 1986;41:207-11.
10. Broderick GA, Gordon D, Hypolite J, Levin RM. Anoxia and corporal smooth muscle dysfunction: A model for ischemic priapism. J Urol 1994;151:259-62.
11. Kim NN, Kim JJ, Hypolite J, García-Díaz JF, Broderick GA, Tornheim K, Daley JT, Levin R, Saenz de Tejada I. Altered contractility of rabbit penile corpus cavernosum smooth muscle by hypoxia. J Urol 1996;155:772-8.
12. Saenz de Tejada I, Kim NN, Daley JT, Royai R, Hypolite J, Broderick GA, Garcia-Diaz F, Levin R. Acidosis impairs rabbit trabecular smooth muscle contractility. J Urol 1997;157:722-6.
13. Muneer A, Cellek S, Dogan A, Kell PD, Ralph DJ, Minhas S. Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model. Int J Impot Res 2005;17:10-8.
14. Muneer A, Cellek S, Ralph DJ, Minhas S. The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapism. BJU Int 2008;102:988-92.
15. Filippi S, Marini M, Vannelli GB, Crescioli C, Granchi S, Vignozzi L, Luconi M, Ferruzzi P, Morelli A, Forti G, Ledda F, Maggi M. Effects of hypoxia on endothelin-1 sensitivity in thecorpus cavernosum. Mol Hum Reprod 2003;9:765-74.
16. Borderick GA, Lue TF. Evaluation and nonsurgical management of erectile dysfunction and priapism. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ, Kavoussi AR, Novick AC, Partin AW, Peters CA, eds. Campbell's urology. Philadelphia: WB Saunders; 2002:1619-71.
17. Munarriz R, Wen CC, McAuley I, Goldstein I, Traish A, Kim N. Management of ischemic priapism with high-dose intracavernosal phenylephrine: From bench to bedside. J Sex Med 2006;3:918-22.
18. Lin G, Xin ZC, Lue TF, Lin CS. Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 2003;170:S15-8.
19. Granchi S, Vannelli GB, Vignozzi L, Crescioli C, Ferruzzi P, Mancina R, Vinci MC, Forti G, Filippi S, Luconi M, Ledda F, Maggi M. Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. Mol Hum Reprod 2002;8:1053-64.
20. Hashmat AI, Rehman J. Priapism. In: Hashmat AI, Das S, eds. The penis. Philadelphia: Lea & Febiger; 1993.
21. Moreland RB, Traish A, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I. PGE1 suppresses the induction of collagen synthesis by transforming growth factor- beta1 in human corpus cavernosum smooth muscle. J Urol 1995;153:826-34.
22. Nehra A, Goldstein I, Pabby A, Nugent M, Huang YH, de las Morenas A, Krane RJ, Udelson D, Saenz de Tejada I, Moreland RB. Mechanisms of venous leakage: A prospective clinicopathological correlation of corporeal function and structure. J Urol 1996;156:1320-9.
23. Ul-Hasan M, El-Sakka AI, Lee C, Yen TS, Dahiya R, Lue TF. Expression of TGF-beta-1 mRNA and ultrastructural alterations in pharmacologically induced prolonged penile erection in a canine model. J Urol 1998;160:2263-6.
24. Kim JJ, Moon DG, Koh SK. The role of nitric oxide in vivo feline erection under hypoxia. Int J Impot Res 1998;10:145-50.
25. Moon DG, Lee DS, Kim JJ. Altered contractile response of penis under hypoxia with metabolic acidosis. Int J Impot Res 1999;11:265-71.
26. Chen KK, Chan JY, Chang LS, Chen MT, Chan SH. Intracavernous pressure as an experimental index in a rat model for the evaluation of penile erection. J Urol 1992;147:1124-8.
27. Munarriz R, Park K, Huang YH, Saenz de Tejada I, Moreland RB, Goldstein I, Traish AM. Reperfusion of ischemic corporal tissue: Physiologic and biochemical changes in an animal model of ischemic priapism. Urology 2003;62:760-4.
28. Evliyaoglu Y, Kayrin L, Kaya B. Effect of allopurinol on lipid peroxidation induced in corporeal tissue by venoocclusive priapism in a rat model. Br J Urol 1997;80:476-9.
29. Evliyaoǧlu Y, Kayrin L, Kaya B. Effect of pentoxifylline on veno-occlusive priapism-induced corporeal tissue lipid peroxidation in a rat model. Urol Res 1997;25:143-7.
30. Jin YC, Gam SC, Jung JH, Hyun JS, Chang KC, Hyun JS. Expression and activity of heme oxygenase-1 in artificially induced low-flow priapism in rat penile tissues. J Sex Med 2008;5:1876-82.
31. Uluocak N, Ati{dotless}lgan D, Erdemir F, Parlaktas BS, Yasar A, Erkorkmaz U, Akbas A. An animal model of ischemic priapism and the effects of melatonin on antioxidant enzymes and oxidative injury parameters in rat penis. Int Urol Nephrol 2010. Jan 30 [Epub ahead of print] doi: 10.1007/s11255-010-9706-y.
32. Sanli O, Armagan A, Kandirali E, Ozerman B, Ahmedov I, Solakoglu S, Nurten A, Tunç M, Uysal V, Kadioglu A. TGF-beta1 neutralizing antibodies decrease the fibrotic effects of ischemic priapism. Int J Impot Res 2004;16:492-7.
33. Tong Y, Tar M, Davelman F, Christ G, Melman A, Davies KP. Variable coding sequence protein A1 as a marker for erectile dysfunction. BJU Int 2006;98:396-401.
34. Tong Y, Tar M, Monrose V, DiSanto M, Melman A, Davies KP. hSMR3A as a marker for patients with erectile dysfunction. J Urol 2007;178:338-43.
35. Tong Y, Tar M, Melman A, Davies K. The opiorphin gene (ProL1) and its homologues function in erectile physiology. BJU Int 2008;102:736-40.
36. Kanika ND, Tar M, Tong Y, Kuppam DS, Melman A, Davies KP. The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway. Am J Physiol Cell Physiol 2009;297:C916-27.
37. Champion HC, Bivalacqua TF, Takimoto E, Kass DA, Burnett AL. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci USA 2005;102:1661-6.
38. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002;416:337-9.
39. Huang PL. Lessons learned from nitric oxide synthase knockout animals. Semin Perinatol 2000;24:87-90.
40. Huang PL, Huamg Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-42.
41. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993;75:1273-86.
42. Nelson JH, Winter CC. Priapism: Evolution of management in 48 patients in a 22-year series. J Urol 1977;117:455-8.
43. Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980;140:1434-7.
44. Adeyoju AB, Olujohungbe AB, Morris J, Yardumian A, Bareford D, Akenova A, Akinyanju O, Cinkotai K, O'Reilly PH. Priapism in sickle cell disease; incidence, risk factors and complications-An international multicentre study. BJU Int 2002;90:898-902.
45. Bivalacqua TJ, Musicki B, Hsu LL, Gladwin MT, Burnett AL, Champion HC. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. J Sex Med 2009;6:2494-504.
46. Claudino MA, Franco-Penteado CF, Corat MA, Gimenes AP, Passos LA, Antunes E, Costa FF. Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway. J Sex Med 2009;6:2187-96.
47. Bivalacqua TJ, Ross AE, Strong TD, Gebska MA, Musicki B, Champion HC, Burnett AL. Attenuated RhoA/Rho-kinase Signaling in Penis of Transgenic Sickle Cell Mice. Urology 2010;76:510 e7-510 e12.
48. Pászty C, Brion CM, Manci E, Witkowska HE, Stevens ME, Mohandas N, Rubin EM. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 1997;278:876-8.
49. Hsu LL, Champion HC, Campbell-Lee SA, Bivalacqua TJ, Manci EA, Diwan BA, Schimel DM, Cochard AE, Wang X, Schechter AN, Noguchi CT, Gladwin MT. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 2007;109:3088-98.
50. Blackburn MR. Too much of a good thing: Adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol Sci 2003;24:66-70.
51. Andersson KE, Stief CG. Neurotransmission and the contraction and relaxation of penile erectile tissues. World J Urol 1997;15:14-20.
52. Hershfield MS. Adenosine deaminase deficiency: Clinical expression, molecular basis, and therapy. Semin Hematol 1998;35:291-8.
53. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Adenosine and brain ischemia. Cerebrovasc Brain Metab Rev 1992;4:346-69.
54. Blackburn MR, Aldrich M, Volmer JB, Chen W, Zhong H, Kelly S, Hershfield MS, Datta SK, Kellems RE. The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase dediciency. J Biol Chem 2000;275:32114-21.
55. Blackburn MR, Kellems RE. Adenosine deaminase deficiency: Metabolic basis of immune deficiency and pulmonary inflammation. Adv Immunol 2005;86:1-41.
56. Yuan JH, Chunn JL, Mi TJ, Molina JG, Abbasi S, Sun CX, Zhang J, Miller CS, Westney OL, Blackburn MR, Kellems RE, Xia Y, Wang R. Adenosine deaminase knockout in mice induces priapism via A2b receptor. J Urol 2007;177(Suppl):227.
57. Mi T, Abbasi S, Zhang H, Uray K, Chunn JL, Xia LW, Molina JG, Weisbrodt NW, Kellems RE, Blackburn MR, Xia Y. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest 2008;118:1491-501.
58. Wen J, Jiang X, Dai Y, Zhang Y, Tang Y, Sun H, Mi T, Kellems RE, Blackburn MR, Xia Y. Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism. J Sex Med 2009;7:3011-22.
59. Wen J, Jiang X, Dai Y, Zhang Y, Tang Y, Sun H, Mi T, Phatarpekar PV, Kellems RE, Blackburn MR, Xia Y. Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling. FASEB J 2010;24:740-9.